THERAPEUTIC ANTIBODIES INC /DE (CIK: 0000944744) EDGAR, Information, Filings... CompaniesBIO.Com

THERAPEUTIC ANTIBODIES INC /DE

Mailing address
1207 17TH AVENUE SOUTH, STE 103, NASHVILLE, Delaware, 37212
Phone
6153271027
State location
Tennessee
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES
Filings
N/A

THERAPEUTIC ANTIBODIES INC /DE (CIK: 0000944744) is an American company incorporated in the state of Tennessee. Head office is located at 1207 17TH AVENUE SOUTH, STE 103, NASHVILLE, Tennessee, 37212. Work in the industry 8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES. THERAPEUTIC ANTIBODIES INC /DE is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by THERAPEUTIC ANTIBODIES INC /DE

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000950144-99-011206 ( Act) Size: 3 KB	Sep-15-1999	000-25978 99712054
8-K	Document	Current report filing Acc-no: 0000950144-99-011145 ( Act) Size: 5 KB	Sep-14-1999	000-25978 99710800
DEFM14A	Document	Definitive proxy statement relating to a merger,acquisition, or disposition Acc-no: 0000950150-99-001001 ( Act) Size: 1175 KB	Aug-19-1999	000-25978 99696247
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0000950144-99-010186 ( Act) Size: 160 KB	Aug-13-1999	000-25978 99689766
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950144-99-010182 ( Act) Size: 53 KB	Aug-13-1999	000-25978 99689688
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950144-99-010041 ( Act) Size: 326 KB	Aug-13-1999	000-25978 99686745
8-K	Document	Current report filing Acc-no: 0000950144-99-006783 ( Act) Size: 22 KB	May-26-1999	000-25978 99635120
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950144-99-006303 ( Act) Size: 47 KB	May-17-1999	000-25978 99626836
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0000950144-99-005128 ( Act) Size: 40 KB	Apr-30-1999	000-25978 99606554
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950144-99-004240 ( Act) Size: 14 KB	Apr-08-1999	000-25978 99589846
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0000950144-99-003773 ( Act) Size: 309 KB	Mar-31-1999	000-25978 99582027
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0000950144-99-002003 ( Act) Size: 15 KB	Feb-16-1999	000-25978 99544574
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0000950144-99-001950 ( Act) Size: 15 KB	Feb-16-1999	000-25978 99543183
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0000950144-99-001944 ( Act) Size: 15 KB	Feb-16-1999	000-25978 99543015
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0000950144-99-001943 ( Act) Size: 15 KB	Feb-16-1999	000-25978 99543003
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0000950144-99-001940 ( Act) Size: 15 KB	Feb-16-1999	000-25978 99542991
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950144-99-001939 ( Act) Size: 10 KB	Feb-16-1999	005-49566 99542981
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950144-99-001539 ( Act) Size: 9 KB	Feb-12-1999	005-49566 99533589
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950131-99-000883 ( Act) Size: 11 KB	Feb-12-1999	005-49566 99537411
8-K	Document	Current report filing Acc-no: 0000950144-99-000814 ( Act) Size: 5 KB	Feb-02-1999	000-25978 99519547

Recent 20 filings. View all THERAPEUTIC ANTIBODIES INC /DE filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

THERAPEUTIC ANTIBODIES INC /DE overview
THERAPEUTIC ANTIBODIES INC /DE job
THERAPEUTIC ANTIBODIES INC /DE stock
THERAPEUTIC ANTIBODIES INC /DE ownership
THERAPEUTIC ANTIBODIES INC /DE CEO
THERAPEUTIC ANTIBODIES INC /DE documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.